A number of novel phosphinate and phosphate triester derivatives of the anti-viral nucleoskle analogue araA have been prepared. Spectroscopic and analytical data have been collected on both the reagents and the nucleotides. An in vitro assay indicated inhibition of DNA synthesis by mammalian cells, by each of the nucleotide derivatives, in the range 3-30/iM. Inhibition was reduced, but not abolished, for the phosphinates relative to the phosphates. These results are consistent with a mode of action involving release of the free nucleoside araA and the nucleoude araAMP.
INTRODUCTION.
The nucleoside analogue araA, 9-/3-D-arabinofuranosyladenine (1) has found widespread use in the treatment of a number of viral infections, including herpes simplex encephalitis and disseminated herpes zoster 1 . However, as with most nucleoside analogues, araA suffers from a number of limitations. In particular it is subject to rapid enzymatic deactivation by adenosine deaminase 2 , and, along with almost all other nucleoside analogues, it has a deleterious dependence on kinase mediated activation to the 5'-phosphate forms 3 . There are now many reports of the absence, low activity, or deletion, of the appropriate kinase being correlated with poor clinical response 4 . This has prompted the investigation of the bio-active nucleotides as chemotherapeutic agents in their own right. However, little, if any, clinical benefit arises from the use of the pre-formed nucleotide, by comparison to the nucleoside 5 . This is commonly attributed to the poor membrane penetration of the (charged) nucleotide, and the rapid extracellular cleavage to the corresponding nucleoside 6 . There have now been a number of reports detailing the use of uncharged, phosphate triester derivatives of araA 7 , and other chemotherapeutic nucleoside analogues 8 , as possible membrane soluble pro-drugs of the nucleotides. Recently, we found that simple dialkyl phosphate triester derivatives (2a-2d) of araA were potent inhibitors of the incorporation of thymidine into the DNA of mammalian cells 9 . Moreover, there appeared to be a close correlation between degree of inhibition and lipophilicity, suggesting membrane penetration by the intact triesters. A similar observation was also made of analogous phosphate triester derivatives of the anti-cancer drug araC 10 . However, the mechanism by which the phosphate triesters were exerting their biological effect remained unclear. We had hoped that the phosphate triesters of araA would act as intracellular sources of araAMP, via P-O-alkyl cleavage. In this way the dependence of araA on adenosine kinase mediated phosphorylation would be obviated. However, equally possible was cleavage of the P-O-nucleoside link, to yield araA. Whilst clearly not so desirable, the resulting intracellular release of the nucleoside may still have some chemotherapeutic benefit 1 '. We proposed to pursue this question by the synthesis and evaluation of new derivatives, whose structures allowed some mechanisms of action, but precluded others. In particular, phosphinate derivatives of araA were studied, on the grounds of the high chemical and biological stability of the P-C bond 12 . Thus, compounds analogous to the previous phosphate triesters (2a-2d), but bearing methylene bridges from the phosphorus to the alkyl chains, were prepared and evaluated in vitro.
EXPERIMENTAL
All reactions were carried out under scrupulously dry conditions unless otherwise indicated. Pyridine was dried by distillation at atmospheric pressure from calcium hydride onto activated 4A molecular sieves. 'Anhydrous' diethyl ether was further dried over activated 4A molecular sieves. Toluene was dried over activated 4A molecular sieves for 24h. For T.L.C., Merck 60 F254 pre-coated silica plates were employed. For flash column chromatography either Merck Kieselgel 60 or Woelm silica was used. Proton nmr spectra were recorded on a Varian XL200 spectrometer operating at 200MHz. 13 C nmr spectra were obtained on this instrument, operating at 50MHz, or on a Varian VXR400 operating at 100MHz.
3I P spectra were obtained on the former instrument, at 82MHz. Proton spectra were referenced to TMS or sodium 3-(trimethylsilyl)-l-propanesulphonic acid, phosphorus spectra to 85% phosphoric acid, and carbon spectra to methanol; positive shifts are downfield of the reference. Mass spectra were recorded on a VG7070H spectrometer, courtesy of Dr.M.Mmzek (FJMS), or on a VG ZablF, courtesy of the University of London Mass Spectrometry Service (FAB MS). Microanalyses were performed at UCL, courtesy of Mr.A.T.T.Stones. Nucleotide triesters were noted to be hygroscopic, and correct analytical data were frequently not obtained for anhydrous formulae.
9-fi-D-ArabinoJuranosyladenine 5 '-dibutyl phosphinate (3a).
Dibutyl phosphinic chloride (4a) (1.47g, 7.48mmol) was added with vigorous stirring to a solution of araA (1) (l.OOg, 3.74mmol) in pyridine (120ml) at ambient temperature. After 2h, water (67/d, 3.74mmol) was added, and the solvent removed under reduced pressure. The residue was purified by column chromatography on silica, with elution by 3% methanol, 1 % triethylamine in chloroform. Pooling and evaporation of appropriate fractions gave the product (0.89g, 56%), mp 82-5 °C. 
9-0-D-Arabinojuranosyladenine 5 '-dibenzyi phosphinate (3b).
This was prepared by an analogous method to (3a) above, except that the reaction time was extended to 17h, and the chromatographic column was eluted with 5% methanol, 1 % triethylamine in chloroform. Thus, from 0.40g of (1) + , 100); Found C 57.12%, H 5.61, N 13.39, P 6.07; C^H^sOjP requires C 58.12, H 5.29, N 14.13, P 6.25, C^HifiNjOsP.tl^Olo.j requires C 57.14, H 5.39, N 13.88, P 6.14.
9-fi-D-Arabinofuranosyladenine 5'-diphenyl phosphate (2e).
This was prepared by an analogous method to (3b) above, except that the chromatographic column was eluted with a gradient of 0-5% methanol in chloroform. Thus, from l.OOg of (1) 
RESULTS AND DISCUSSION
The first target compound was the dibutyl phosphinate (3a). Since the Van der Waals radii for methyl and oxygen moieties are not dissimilar 13 , this compound should be comparable to the previously prepared dipropyl phosphate (2b). Similar biological activities might be expected, if the compounds were acting as depot forms of araA. However, the phosphinate would be expected to be much less active, if the mode of action were release of araAMP.
A reasonable route to (3a) appeared to be the reaction of araA with dibutyl phosphinic chloride (4a); the latter reagent being produced in two steps. Thus, diethyl phosphite was allowed to react with the Grignard reagent prepared from 1-bromobutane, followed by hydrolysis, and oxidation 14 to yield dibutyl phosphinic acid
15
. This was chlorinated with thionyl chloride 16 to yield (4a) 17 . The I3 C nmr spectra of the acid and the chloride (4a) are of some interest. In both cases, large (93, 73Hz) 1-bond phosphorus coupling constants are observed. However, in the former, the 2-bond coupling is larger than the 3-bond parameter (16, 4Hz) , whereas in the latter the situation is reversed. In this regard the chloride is similar to the previously discussed dialkyl phosphorochloridates 9 . Using established methods 9 compound (4a) was allowed to react with un-protected araA in anhydrous pyridine at ambient temperature. TLC indicated a more rapid reaction than had been noted for the corresponding phosphate, dipropyl phosphorochloridate. However, despite satisfactory TLC properties, the product (3a) did not run well on silica column chromatography, being eluted as a broad, non-homogeneous band. However, this problem was solved by the inclusion of triethylamine in the elution mixture. The product (3a) was fully characterised by spectroscopic and analytical means. We had previously noted 9 the non-equivalence of the two alkyl chains attached to the phosphorus, in the nmr spectra of the analogous phosphate triesters (2a-d); this was observed here too. However, the splittings for diastereotopic carbon atoms in the chains were now much more pronounced; being ca. 0.1 ppm here, as compared to ca. 0.01 ppm previously. Irradiation experiments in the 'H nmr spectrum confirmed that the most downfield methyl and methylene resonances were attributable to the same chain. As expected, a single resonance was observed in the 3I P nmr spectrum of (3a) with a chemical shift (6 ca. 60 ppm) close to that reported for Bu 2 P(O)OEt (Sp ca. 54 ppm 18 ). The structure of (3a) was further confirmed by mass spectrometry, both El and FAB revealed MH + peaks; in the latter, this was the base peak in fact. Lastly, the purity of (3a) was confirmed by microanalysis.
The next phosphinate to be pursued was the dibenzyl compound (3b). Thus, dibenzyl phosphinic acid was prepared by the method of Sauvage 19 , involving the reaction of benzyl magnesium chloride with phosphoryl chloride, followed by acid hydrolysis. The yield of this product was low (< 10%), but its melting point was identical to that reported 20 , and spectroscopic data fully confirmed its structure and purity 21 . This material was converted to the phosphinic chloride (4b) in high yield, using thionyl chloride as above 1622 . Compound (4b) was then allowed to react with araA in pyridine as above, to yield (3b). The product was fully characterised by nmr spectroscopy, mass spectrometry, and analysis.
For the purposes of comparison the diphenyl phosphate triester derivative (2e) of araA was prepared by the reaction of the nucleoside with diphenyl phosphorochloridate 23 . The product (2e) was characterised by nmr spectroscopy, mass spectrometry, and analysis. The 31 P nmr resonance (6p ca. -11 ppm) was rather upfield of that previously noted for the analogous dialkyl phosphates (2a-2d) 9 , but similar to that reported for the model compound diphenyl t-butyl phosphate (6p ca. -12 ppm 24 ). The comparative phosphate triester (2b) was prepared exactly as previously noted 9 . Thus, we were able to compare the biological properties of analogous phosphates and phosphinates, both in the alkyl (2b vs. 3a) and aryl (2e vs. 3b) series. The inhibition of DNA synthesis by these compounds was studied by the procedure we have recently described 9 , the results being summarised in table 1. At 30/iM araA caused 78% inhibition of thymidine incorporation into cellular DNA under assay conditions. Under these conditions phosphate (2b) displayed 45% inhibition, whilst phosphinate (3a) caused only 24% inhibition. At 3/tM araA caused 31% inhibition of DNA synthesis, with (2b) and (3a) displaying 23% and 6% inhibition respectively. At 30/iM the phenyl phosphate (2e) was equi-active with araA, causing 79% inhibition, whilst the phosphinate (3b) demonstrated only 52% inhibition. At 3/iM the figures for (2e) and (3b) were 21 % and 16% respectively.
Two conclusions are evident. Firstly, in both cases, at both concentrations studied, the phosphinates (3a) and (3b) retain a significant inhibitory effect on DNA synthesis. Thus, the stabilising of the phosphorus to alkyl link has not removed the biological activity of the phosphate triesters, (2b) and (2e). This would suggest that (2b) and (2e), and by inference the rest of this series (2a-e), do not act solely by release of araAMP, via cleavage of (6) 20 (6) The inhibition of the incorporation of tritiated thymidine into DNA in the presence of compounds (1), (2b), (2e), and (3a-b) at 3 and 30^M, relative to distilled water control. For details see reference (9 the alkyl-phosphate bonds. Secondly, in every case the activities of the phosphinates are lower than those of the analogous phosphates, under identical conditions. Indeed, a twotailed Student t-test reveals this difference to be significant (P<5%) for (2b) vs. (3a) at 3/iM and 30/tM, and for (2e) vs. (3b) at 30/iM. This is in keeping with the suggestion that the lability of the phosphate to alkyl link in the phosphates enhances their activity relative to that of the phosphinates. The most obvious mechanism with which this would be consistent involves cleavage of the phosphate triesters to yield araAMP, or a derivative thereof.
In an effort to pursue the mechanism of action of the phosphates and phosphinates herein described, the compounds (2b), (2e), (3a), and (3b) were incubated under assay conditions, but excluding the cellular material. In no case was any hydrolysis noted by TLC, over 24h at 37 °C. Thus, extracellular hydrolysis is unlikely to be involved in the mechanism of action of the compounds. However, whether the compounds undergo intracellular hydrolysis, or act without hydrolysis remains uncertain.
In conclusion, phosphinate derivatives retain some of the biological activity of their phosphate triester parents, but the degree of activity is significantly less for the former. This indicates a dual mechanism of action for the phosphate triesters. Thus, at least to some degree, the phosphate triesters may be acting as intracellular sources of free nucleotides.
